Inflammatory Response Research, Inc.
Records under this name other than the patents Inflammatory Response Research, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 4 of 4 · Back to Inflammatory Response Research, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,044,479 | Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,522,148 | Use of levocetirizine and montelukast in the treatment of traumatic injury Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,669,025 | Use of levocetirizine and montelukast in the treatment of vasculitis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,669,026 | Use of levocetirizine and montelukast in the treatment of autoimmune disorders Formerly held In force · From the USPTO record | In force | From the USPTO record |